Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments

Despite recent advances in the systemic treatment of gastroesophageal cancers, prognosis remains poor. Comprehensive molecular analyses have characterized the genomic landscape of gastroesophageal cancer that has established therapeutic targets such as human epidermal growth factor receptor 2 (HER2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Anderley, Johnston, Edwina, Lau, David K, Starling, Naureen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553429/
https://www.ncbi.nlm.nih.gov/pubmed/36238135
http://dx.doi.org/10.2147/OTT.S282718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553429/
https://www.ncbi.nlm.nih.gov/pubmed/36238135
http://dx.doi.org/10.2147/OTT.S282718

Ejemplares similares